This work was funded by the Ministry of Education, Culture and Science (Gravity program 024.001.035), the Netherlands Organisation for Scientific Research (NWO), the European Research Council (FP7/2007-2013) ERC Grant Agreement 308045 and conducted within the LSH TKI framework. This research forms part of the Project P1.03 PENT of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. This project was supported by ICIN - Netherlands Heart Institute (<a href="www.icin.nl">www.icin.nl</a>) and the &#8220;Wijnand M. Pom Stichting&#8221;. The authors would like to thank Henk Janssen and Joris Peters for the synthesis of the UPy-hydrogelator and Remco Arts for providing the mRuby2. We thank Bert Meijer, Tonny Bosman, Roxanne Kieltyka, Stijn Kramer, Joost Sluijter, Imo Hoefer, and Frebus van Slochteren for the many useful discussions and Marlijn Jansen, Joyce Visser, Grace Croft and Martijn van Nieuwburg for technical assistance.

NOTE: All in vivo experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals by the Institute of Laboratory Animal Resources. Experiments were approved by the Animal Experimentation Committee of the Medicine Faculty of the Utrecht University, the Netherlands.
1. Formulation of the Hydrogel
<ol>
	<li>To prepare 1 ml of the 10 wt% gel, dissolve 100 mg of the UPy-hydrogelator in a vial in 900 &#956;l PBS pH 11.7 by stirring at 70 &#176;C for 1 hr using a magnetic stirrer. Afterwards cool the viscous solution down to room temperature. The solution should now have a pH of approximately 9.0. This solution can be stored for several days.</li>
	<li>Pipette the appropriate amount of drug or biomolecule that is dissolved in neutral PBS into the viscous solution and stir for 10 min to reach a uniform distribution. If the solution becomes too viscous, shortly warm it with hot water.</li>
	<li>Place the solution for 1 hr under an UV-lamp to sterilize.</li>
</ol>
2. Analysis of Hydrogel
<ol>
	<li>Rheological assessment of the solution
	<ol>
		<li>Before loading the gel, mount the 25 mm plate-plate geometry in the rheometer, set the temperature to 20 &#176;C and load the plate with water to prevent evaporation of the gel during measurement.</li>
		<li>Pipette 300 &#956;l of the solution onto a 25 mm plate-plate geometry on a rheometer maintained at 20 &#176;C and lower the plates to obtain a 0.5 mm gap distance.</li>
		<li>Record shear viscosity as function of shear stress from 0.1 to 500 Pa with 10 points per decade.</li>
	</ol>
	</li>
	<li>Rheological assessment of the gel
	<ol>
		<li>Pipette 300 &#956;l of the solution onto the plate and pipette a total of 4.2 &#956;l of 1 M HCl at different places on the solution to induce the gel formation.</li>
		<li>Lower the plates to a gap distance of 0.5 mm and let the gel cure for approximately 30 min. During this curing process, measure the storage and loss moduli at low frequency and strain, for example respectively 1 rad/sec and 0.5%.</li>
		<li>After the gel has cured (after approximately 30 min), record storage and loss moduli as function of the frequency (0.1-100 rad/sec) and subsequently as function of the strain (0.1-1,000%).</li>
	</ol>
	</li>
</ol>
3. Erosion and Release Experiments
<ol>
	<li>Transfer 100 &#181;l of the viscous solution containing the drug or biomolecule into a poly(ethylene terephthalate) hanging cell culture insert for 24-wells plate with pore size 8.0 &#181;m. To prevent leakage of the polymer solution while in the liquid phase, cover the bottom of the inserts with Parafilm (Figure 2A).</li>
	<li>Immediately afterwards pipette 1.4 &#181;l of 1 M HCl on top of the viscous solution to reduce the pH to approximately 7.0-7.2 and let the gel cure inside the insert for about 30 min.</li>
	<li>Remove the Parafilm from the inserts, place the insert in a 24-well plate and fill the well with 800 &#181;l PBS pH 7.4. Incubate the plate at 37 &#176;C with slow rocking or shaking movement. To prevent evaporation of the solvent, fill remaining empty wells with PBS and seal the 24-well plate with Parafilm (Figure 2B).</li>
	<li>Periodically refresh the PBS and analyze the removed PBS for released UPy erosion product or drug/biomolecule.
	<ol>
		<li>Quantify UPy erosion products or pirfenidone by measuring UV absorbance at 265 nm or 320 nm respectively. For fluorescent protein mRuby2 measure fluorescence emission at 587 nm after excitation at 559 nm.</li>
		<li>Translate measured absorption/emission values to concentrations via predetermined calibration curves.
		<ol>
			<li>Prepare calibration curves dissolving a series of known concentrations of the analyte in buffer and measure the UV absorbance or fluorescent emission of these samples. Interpolate the data using a linear function to determine the concentration of the unknown samples. For non-fluorescent proteins use ELISA detection6.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>
4. Local Injection via a Catheter
<ol>
	<li>Induction of myocardial infarction
	<ol>
		<li>After 12 hr of fasting, excluding water, sedate the pig in its stable by injecting midazolam 0.4 mg/kg, ketamine 10 mg/kg and atropine 0.014 mg/kg intramuscularly.</li>
		<li>Administrate sodium thiopental 5 mg/kg intravenously to induce anesthesia and intubate the pig with an endotracheal tube. Perform balloon-ventilation at a rate of 12/min if needed while transporting the animal to the operating theater.</li>
		<li>On arrival at the operation theater immediately start mechanical positive pressure ventilation with FiO2 0.50, 10 ml/kg tidal volume, and a frequency of 12/min under continuous capnography. Use vet ointment on the eyes to prevent dryness.</li>
		<li>Start balanced anesthesia by continuous intravenous infusion of midazolam 0.5 mg/kg/hr, sufentanil 2.5 &#181;g/kg/hr and pancuronium bromide 0.1 mg/kg/hr. To ensure proper anesthesia continuously monitor ECG, arterial blood pressure, temperature and capnography.</li>
		<li>Intravenously infuse 4.3 mg/kg amiodarone and place the intracardiac defibrillation catheter in the right ventricle using the venous sheeth18.</li>
		<li>Occlude the left anterior descending artery (LAD) distal to the second diagonal branch by intracoronary balloon occlusion, for 90 min, in accordance to previously described protocol18.</li>
	</ol>
	</li>
	<li>Electromechanical mapping
	<ol>
		<li>At four weeks after myocardial infarction, plan the mapping procedure. Prepare the system (Figure 4) in the cathlab for 3D electromechanical mapping (EMM) of the left ventricle. With this system viable, hibernating and infarcted myocardium can be identified without fluoroscopic guidance. To construct such an EM-map acquire&#160;a series of points at multiple locations on the LV endocardial surface by using an ultralow magnetic-field energy source and a sensor-tipped catheter19,20.</li>
		<li>Anesthetize the pig, following protocol steps 4.1.1-4.1.4.</li>
		<li>Place the external reference patch on the pig&#8217;s back.</li>
		<li>Secure vascular access (femoral artery) according to protocol18.</li>
		<li>After obtaining a biplane left ventricular angiogram in the 25&#176; right anterior oblique (RAO) and 40&#176; left anterior oblique (LA) view to estimate left ventricular size, give 75 U/kg of heparin.</li>
		<li>Advance an 8 French-mapping (D or F curve) catheter under fluoroscopic guidance to the descending aorta, aortic arch and across the aortic valve into the left ventricle (LV).</li>
		<li>Orientate the tip of the catheter to the apex of the LV to acquire the first data, followed by outflow tract, lateral and posterior points to form a 3D silhouette, defining the borders of the ventricle.</li>
		<li>Obtain subsequent points until all endocardial segments have been sampled by dragging the mapping catheter over the endocardium and sequentially acquiring the location of the tip while in contact with the endocardium21,22.</li>
		<li>Define the target area, that is where electrical activity is (near) normal and mechanical movement impaired, so-called hibernating myocardium (Figure 6).</li>
	</ol>
	</li>
	<li>Intramyocardial injection
	<ol>
		<li>Replace the mapping catheter by the intramyocardial injection catheter which is composed of a 27-gauge needle and a core lumen inside an 8 French catheter (Figure 5A and B). To deliver specific amounts, load a volume-graded syringe with approximately 2 ml of the hydrogel solution and place it into a syringe pump.</li>
		<li>Adjust the needle extension at 0&#176; and 90&#176; flex and place 0.1 ml of the hydrogel solution to fill the needle dead space. Then, place the injection catheter tip across the aortic valve and into the target area.</li>
		<li>Meet the following criteria for an injection position inside the target area determined in 4.2.9: (1) perpendicular position of the catheter to the LV wall; (2) excellent loop stability (&#60;4 mm) as calculated by the EMM-system; and (3) underlying voltage &#62;6.9 mV21.
		<ol>
			<li>Advance the needle into the myocardium, (4) confirmed by a premature ventricular contraction of the LV, and inject 0.1-0.3 ml of the hydrogel in a bolus at a constant rate of approximately 0.4-0.5 ml/min using the syringe pump. Repeat this at 6-10 different positions as diffuse as possible. The natural pH of the tissue will neutralize the solution after injection, upon which the hydrogel is formed.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Sacrifice
	<ol>
		<li>Post-procedure, humanely sacrifice the animal by exsanguination. Cut the inferior caval vein and remove blood with a suction device. Induce ventricular fibrillation by placing a 9 V battery on the apex.</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Levy, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Long-Term+Trends+in+the+Incidence+of+and+Survival+with+Heart+Failure.">Long-Term Trends in the Incidence of and Survival with Heart Failure.</a> The New England Journal of Medicine. 347 (18), 1397-1402 (2002).</li><li>Roger, V. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Heart+disease+and+stroke+statistics&#8212;2012+update:+a+report+from+the+American+Heart+Association.">Heart disease and stroke statistics&#8212;2012 update: a report from the American Heart Association.</a> Circulation. 120 (1), 2-220 (2012).</li><li>Peppas, N. A., Huang, Y., Torres-Lugo, M., Ward, J. H., Zhang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Physicochemical+foundations+and+structural+design+of+hydrogels+in+medicine+and+biology.">Physicochemical foundations and structural design of hydrogels in medicine and biology.</a> Annual Review of Biomedical Engineering. 2 (1), 9-29 (2000).</li><li>Olsen, B. D., Kornfield, J. A., Tirrell, D. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Yielding+Behavior+in+Injectable+Hydrogels+from+Telechelic+Proteins.">Yielding Behavior in Injectable Hydrogels from Telechelic Proteins.</a> Macromolecules. 43 (21), 9094-9099 (2010).</li><li>Guvendiren, M., Lu, H. D., Burdick, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Shear-thinning+hydrogels+for+biomedical+applications.">Shear-thinning hydrogels for biomedical applications.</a> Soft Matter. 8 (2), 260 (2012).</li><li>Bastings, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Fast+pH-Switchable+and+Self-Healing+Supramolecular+Hydrogel+Carrier+for+Guided,+Local+Catheter+Injection+in+the+Infarcted+Myocardium.">A Fast pH-Switchable and Self-Healing Supramolecular Hydrogel Carrier for Guided, Local Catheter Injection in the Infarcted Myocardium.</a> Advanced Healthcare Materials. 3 (1), 70-78 (2014).</li><li>Pawar, G. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Injectable+Hydrogels+from+Segmented+PEG-Bisurea+Copolymers.">Injectable Hydrogels from Segmented PEG-Bisurea Copolymers.</a> Biomacromolecules. 13 (12), 3966-3976 (2012).</li><li>Yoon, H. -. J., Jang, W. -. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Polymeric+supramolecular+systems+for+drug+delivery.">Polymeric supramolecular systems for drug delivery.</a> Journal of Materials Chemistry. 20 (2), 211-222 (2009).</li><li>Christman, K. L., Lee, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biomaterials+for+the+treatment+of+myocardial+infarction.">Biomaterials for the treatment of myocardial infarction.</a> Journal of the American College of Cardiology. 48 (5), 907-913 (2006).</li><li>Yu, L., Ding, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Injectable+hydrogels+as+unique+biomedical+materials.">Injectable hydrogels as unique biomedical materials.</a> Chemical Society Reviews. 37 (8), 1473-1481 (2008).</li><li>Krieg, E., Rybtchinski, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Noncovalent+Water-Based+Materials:+Robust+yet+Adaptive.">Noncovalent Water-Based Materials: Robust yet Adaptive.</a> Chemistry &#8211; A European Journal. 17 (33), 9016-9026 (2011).</li><li>Davis, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Injectable+self-assembling+peptide+nanofibers+create+intramyocardial+microenvironments+for+endothelial+cells.">Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells.</a> Circulation. 111 (4), 442-450 (2005).</li><li>Li, J., Ni, X., Leong, K. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Injectable+drug-delivery+systems+based+on+supramolecular+hydrogels+formed+by+poly(ethylene+oxide)s+and+alpha-cyclodextrin.">Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and alpha-cyclodextrin.</a> Journal of Biomedical Materials Research. Part A. 65 (2), 196-202 (2003).</li><li>Dankers, P. Y. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hierarchical+formation+of+supramolecular+transient+networks+in+water:+a+modular+injectable+delivery+system.">Hierarchical formation of supramolecular transient networks in water: a modular injectable delivery system.</a> Advanced materials. 24 (20), 2703-2709 (2012).</li><li>Dankers, P. Y. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+and+in-vivo+characterization+of+supramolecular+hydrogels+for+intrarenal+drug+delivery.">Development and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery.</a> Biomaterials. 33 (20), 5144-5155 (2012).</li><li>Kieltyka, R. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mesoscale+modulation+of+supramolecular+ureidopyrimidinone-based+poly(ethylene+glycol)+transient+networks+in+water.">Mesoscale modulation of supramolecular ureidopyrimidinone-based poly(ethylene glycol) transient networks in water.</a> Journal of the American Chemical Society. 135 (30), 11159-11164 (2013).</li><li>Vrijsen, K. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiomyocyte+progenitor+cell-derived+exosomes+stimulate+migration+of+endothelial+cells.">Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells.</a> Journal of Cellular and Molecular Medicine. 14 (5), 1064-1070 (2010).</li><li>Koudstaal, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Myocardial+infarction+and+functional+outcome+assessment+in+pigs.">Myocardial infarction and functional outcome assessment in pigs.</a> Journal of Visualized Experiments. (86), (2014).</li><li>Koudstaal, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sustained+delivery+of+insulin-like+growth+factor-1/hepatocyte+growth+factor+stimulates+endogenous+cardiac+repair+in+the+chronic+infarcted+pig+heart.">Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.</a> Journal of Cardiovascular Translational Research. 7 (2), 232-241 (2014).</li><li>Spoel, T. I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Non-surgical+stem+cell+delivery+strategies+and+in+vivo+cell+tracking+to+injured+myocardium.">Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.</a> International Journal of Cardiovascular Imaging. 27 (3), 367-383 (2011).</li><li>Gepstein, L., Hayam, G., Shpun, S., Ben-Haim, S. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hemodynamic+evaluation+of+the+heart+with+a+nonfluoroscopic+electromechanical+mapping+technique.">Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique.</a> Circulation. 96 (10), 3672-3680 (1997).</li><li>Gy&#246;ngy&#246;si, M., Dib, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Diagnostic+and+prognostic+value+of+3D+NOGA+mapping+in+ischemic+heart+disease.">Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.</a> Nature Reviews Cardiology. 8 (7), 393-404 (2011).</li><li>Siepmann, J., Siepmann, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Modeling+of+diffusion+controlled+drug+delivery.">Modeling of diffusion controlled drug delivery.</a> Journal of Controlled Release Official Journal of the Controlled Release Society. 161 (2), 351-362 (2012).</li><li>Kim, H., Fassihi, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Application+of+binary+polymer+system+in+drug+release+rate+modulation.+2.+Influence+of+formulation+variables+and+hydrodynamic+conditions+on+release+kinetics.">Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.</a> Journal of Pharmaceutical Sciences. 86 (3), 323-328 (1997).</li><li>Pape, A. C. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mesoscale+characterization+of+supramolecular+transient+networks+using+SAXS+and+rheology.">Mesoscale characterization of supramolecular transient networks using SAXS and rheology.</a> International Journal Of Molecular Sciences. 15 (1), 1096-1111 (2014).</li><li>Lee, B. H., Vernon, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> In Situ-Gelling, Erodible N-Isopropylacrylamide Copolymers. Macromolecular Bioscience. 5 (7), 629-635 (2005).</li><li>Annabi, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=25th+Anniversary+Article:+Rational+Design+and+Applications+of+Hydrogels+in+Regenerative+Medicine.">25th Anniversary Article: Rational Design and Applications of Hydrogels in Regenerative Medicine.</a> Advanced Materials. 26 (1), 85-124 (2014).</li><li>Asai, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+polymer+hydrogels+by+in+situ,+rapid+and+reversible+self-gelation.">Protein polymer hydrogels by in situ, rapid and reversible self-gelation.</a> Biomaterials. 33 (21), 5451-5458 (2012).</li><li>Peppas, N. A., Hilt, J. Z., Khademhosseini, A., Langer, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hydrogels+in+Biology+and+Medicine:+From+Molecular+Principles+to+Bionanotechnology.">Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology.</a> Advanced Materials. 18 (11), (2006).</li><li>Lutolf, M. P., Hubbell, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Synthetic+biomaterials+as+instructive+extracellular+microenvironments+for+morphogenesis+in+tissue+engineering.">Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.</a> Nature Biotechnology. 23 (1), 47-55 (2005).</li></ol>

The authors have nothing to disclose.

A key challenge is to obtain a solution which is injectable through a long catheter while keeping the solution compatible with the bioactive compounds. Although the pH should be increased to increase injectability, bioactive compounds such as growth factors are fragile molecules that should be handled carefully. We monitor the pH of the solution closely using a pH meter after adding the hydrogelator to confirm it is pH 9.0 before adding any bioactive components. Initially, several rounds of adjusting the starting pH of the PBS were necessary to end with the right pH. Furthermore, because we use relatively viscous solutions and a long thin catheter, a large pressure drop is present (in the order of 0.5 MPa, depending on the speed of injection). Therefore, special care should be taken in selecting the right connections between the syringe and the catheter. A syringe pump supports controlled injection, as applying such forces by hand is challenging. For in vitro experiments, the solution was gelated by neutralizing the solution with HCl, while in vivo this is done by the natural pH of the tissue. Therefore, it is important to add the right amount of HCl to prevent an overshoot in pH. The diffusion of this acid is probably the limiting factor in the gelation of the hydrogel in in vitro experiments; however, in vivo the liquid would have a high contact surface area with neutralizing tissue, which will most likely result in a faster and more evenly gelation compared to dropwise addition of concentrated acid. Moreover, the gel switching is much faster with this mild procedure as compared to previously used methods (0.5 hr vs 2 hr)25. Using the body&#8217;s natural pH for switching of the material properties is very appealing since the transition is swift, reversible, cannot occur inside the catheter and is in vivo fully automatic. These properties give advantages over e.g. thermal switchable gels26, where risk of gelation in a catheter due to temperature changes is present, gels that require photo-induced polymerization, which is challenging due to limited light penetration and radical formation27, or gels that require co-injection of a polymerization initiator or accellerator28.
Successful release of a drug from the hydrogel largely depends on the size of the drug. As shown, the small molecule drug is released immediately while the gradual release of the model protein over 1 week shows the promise of these hydrogels as delivery systems for growth factors. In general, hydrogels are more promising as delivery tool for larger objects such as proteins, exosomes and cells29,30.
The 3-D electromechanical mapping and injection procedure provides a clinically validated catheter-based delivery approach for various myocardial regenerative therapies, such as hydrogels. The added value of this technology compared to other non-surgical delivery techniques is the treatment planning, making it possible to differentiate normal, infarcted and hibernating myocardium and to guide therapies in the area of interest. Drawbacks of this approach concern the required technical skills and the time consuming and expensive procedure20. In the presented porcine model of myocardial infarction electromechanical mapping was followed by guided intramyocardial injections with the bioactive supramolecular UPy-hydrogel. Other combinations with regenerative therapies have to be tested in vitro and in vivo to gain more success in this emerging field. Furthermore, optimization of injectability and sterilization procedures have to be performed to successfully translate this method to a clinical setting.

Although the treatment of acute myocardial infarction has significantly improved survival rates, the chronic ischemic heart failure is a major public health problem that progresses with an aging population. There are approximately 6 million heart failure patients in the US with an estimated 25% increase in prevalence in 20301,2. Initial loss of myocardial tissue leads to cardiac remodeling and eventually causes chronic heart failure. Except for heart transplantation, there is no real treatment for this group of patients. The increasing shortcoming of donor hearts emphasizes the need to develop new available therapies to reverse this process of remodeling. Therefore, a goal for future therapies is the regeneration of lost myocardium.
Hydrogels are interesting materials in the field of regenerative medicine because of their biocompatibility, and their sensitivity to external triggers3. Injectable hydrogels offer advantages over non-injectable hydrogels in their use in minimal invasive surgery4. These injectable hydrogels can be applied through a syringe because of their switchability within physiological conditions5, and in principle allow for catheter-based injection approaches6. Different strategies have been used for injectable materials, ranging from chemical crosslinking after injection to physical crosslinking by either temperature, pH and shear-thinning behaviour4,7,8. Although several systems have shown easy injectability via a syringe9,10, full catheter-compatibility has not been shown often6.
Hydrogels prepared from supramolecular polymers are formed by non-covalent interactions which can be switched conveniently from a gel to a solution state, and vice versa using environmental triggers11. Furthermore, the low molecular weight precursors allow for easy processability12,13. The mild conditions required for switching allow the addition of various biological active components such as often difficult to handle growth factors.
Supramolecular transient networks in water based on poly(ethylene glycol) (PEG), end-modified with ureido-pyrimidinone (UPy) moieties14 have shown the benefits of non-covalent interactions in combination with biomedical applications and have been used as drug delivery system in the heart6 and under the renal capsule15. These networks are formed by dimerization of the UPy-groups shielded from the aqueous environment by alkyl spacers forming a hydrophobic pocket. Urea hydrogen bonding facilitates subsequent stacking of these dimers into nanofibers. Due to the reversible interaction of the UPy-UPy dimer, triggers such as pH and temperature can be used to switch from solutions to gels. The use of a synthetic motif allows for design of the molecule and gel properties by for example tuning length of the PEG-chains and alkyl spacers14,16.
Moreover, several bioactive components can be incorporated by simply mixing the supramolecular hydrogelator solution before injection, with drugs or bioactive species, such as growth factors or exosomes, respectively. Exosomes are small membrane vesicles that contain cytosolic derivatives. They are secreted by many cells and are involved in intercellular communication. Exosomes derived from cardiomyocyte progenitor cells are suggested to play a role in cardiac protection17.
Here, we describe the protocol of formulation, and in vivo myocardial injection of such a bioactive supramolecular hydrogel. In vitro experiments are described which give on forehand an indication of gel stability and drug release, which allows for tuning of the gel and release properties before application in vivo.

<table border="0" cellpadding="0" cellspacing="0" width="974">
	<tbody>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Name of Material/ Equipment</td>
			<td style="width:375px;">Company</td>
			<td style="width:119px;">Catalog Number</td>
			<td style="width:167px;">Comments/Description</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">1M HCl</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">1M NaOH</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Polystyrene 24-wells plate</td>
			<td style="width:375px;">Falcon</td>
			<td style="width:119px;">353047</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Amiodarone</td>
			<td style="width:375px;">Cordaron I.V. (Sanofini)</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Anton Paar Physica MCR501</td>
			<td style="width:375px;">Anton Paar GmbH</td>
			<td style="width:119px;"></td>
			<td>Equipped with a parallel-plate geometry (25 mm)</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Atropine</td>
			<td style="width:375px;">PCH</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Balloon ventilator</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Cary 50 Scan UV-Visible Spectrophotometer</td>
			<td style="width:375px;">Varian</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Cary Eclipse Fluorescence Spectrophotometer</td>
			<td style="width:375px;">Varian</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Defibrillation patches</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">DMSO</td>
			<td style="width:375px;">Biosolve</td>
			<td style="width:119px;">44705</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Endotracheal tube</td>
			<td style="width:375px;">Covidien</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Heparin</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Ketamine</td>
			<td style="width:375px;">Narketan 10 V&#233;toquinol</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Mapping catheter 115cm&#160;</td>
			<td style="width:375px;">Biosense Webster</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Midazolam</td>
			<td style="width:375px;">Actavis</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">MilliQ</td>
			<td style="width:375px;">MD Milipore MilliQ Integral Water Purification System</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">mRuby2</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">NaCl 0.9% 500cc</td>
			<td style="width:375px;">Braun</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">NOGA guided Myostar injection catheter</td>
			<td style="width:375px;">Biosense Webster</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">NOGA-RefStar EFO-patch</td>
			<td style="width:375px;">Biosense Webster</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Pancuronium bromide</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Parafilm</td>
			<td>VWR</td>
			<td>IKAA3801100</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">PBS</td>
			<td style="width:375px;">Sigma Aldrich</td>
			<td style="width:119px;">P4417&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">PET millicel</td>
			<td style="width:375px;">Millipore</td>
			<td style="width:119px;">PIEP12R48</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Pirfenidone</td>
			<td style="width:375px;">Sigma Aldrich</td>
			<td>P2116</td>
			<td>Used from 100mM stock in DMSO</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Sodiumthiopental</td>
			<td style="width:375px;">Inresa</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Sufentanil</td>
			<td style="width:375px;">Sufentanil-Hameln</td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Tegaderm</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">UPy-PEG10k</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">UV-Lamp</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Vet ointment</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:315px;">Visipaque contrastfluid 100cc</td>
			<td style="width:375px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
	</tbody>
</table>

an injectable and drug-loaded supramolecular hydrogel for local catheter injection into the pig heart

Regeneration of lost myocardium is an important goal for future therapies because of the increasing occurrence of chronic ischemic heart failure and the limited access to donor hearts. An example of a treatment to recover the function of the heart consists of the local delivery of drugs and bioactives from a hydrogel. In this paper a method is introduced to formulate and inject a drug-loaded hydrogel non-invasively and side-specific into the pig heart using a long, flexible catheter. The use of 3-D electromechanical mapping and injection via a catheter allows side-specific treatment of the myocardium. To provide a hydrogel compatible with this catheter, a supramolecular hydrogel is used because of the convenient switching from a gel to a solution state using environmental triggers. At basic pH this ureido-pyrimidinone modified poly(ethylene glycol) acts as a Newtonian fluid which can be easily injected, but at physiological pH the solution rapidly switches into a gel. These mild switching conditions allow for the incorporation of bioactive drugs and bioactive species, such as growth factors and exosomes as we present here in both in vitro and in vivo experiments. The in vitro experiments give an on forehand indication of the gel stability and drug release, which allows for tuning of the gel and release properties before the subsequent application in vivo. This combination allows for the optimal tuning of the gel to the used bioactive compounds and species, and the injection system.

Typical results obtained from the oscillatory rheological measurements on both the solution and the gel are shown in Figure 1. For injection through a long catheter, a Newtonian fluid with low viscosity is desirable. Viscosity was measured as function of shear rate, showing that at pH 8.5 the solution is shear thinning but at pH 9.0 and 9.5 the solutions behave as Newtonian fluids as evidenced by the constant viscosity of 0.54 and 0.36 Pa&#183;sec, respectively (Figure 1A). After neutralizing the samples, the samples show a solid-like response observed by a storage modulus G&#8242; which is larger than the loss modulus G&#8243; and therefore a tan&#948; = G&#8243;/G&#8242; &#60;1 (Figure 1B). The gel obtains its final strength within 30 minutes. Oscillatory rheological measurements show a typical solid-like response with G&#8242; almost independent of the angular frequency and G&#8242; &#62;G&#8243; for all frequencies measured (Figure 1C).
Essential for the use as drug delivery system is the erosion of the hydrogel over time. The supramolecular interactions are inherently dynamic and allow for a slow erosion of the gel in vitro. Erosion and release experiments are performed at 37 &#176;C using porous well inserts (Figure 2A and B). By tuning the length of the hydrophobic and hydrophilic block14, a gel that erodes over a period of several weeks can be obtained (Figure 3A). The gel erodes 25% in 2 weeks with an initial erosion of 10% in the first day, presumably due to initial swelling of the hydrogel. As example, both the release of a small molecule drug (pirfenidone), and the release of a model fluorescent protein (mRuby2) was studied. A fluorescent model protein allows for an easy readout; however, in vitro release experiments can also be performed on other proteins using ELISA for quantification6. The small molecule drug is released within a day, while bigger molecules such as proteins are gradually released over 1 week (Figure 3B). Fitting the release profile of mRuby2 up to 60% release with the semi-empirical Korsmeyer-Peppas model indicates release due to diffusion (n = 0.44)23. The absence of an offset in the (adapted) Korsmeyer-Peppas model shows that there is no burst release present for mRuby224. Because of the limited amount of data points with a release lower than 60% for pirfenidone, no fitting was performed on this release profile.
The catheter navigation system consists of a communication unit console, a workstation (Figure 4), a triangular location pad (generating a low magnetic field) with an external reference patch, and two catheters, the sensor-tipped mapping and the injection catheter (Figure 5).
After post-processing analysis has filtered unstable points the 3D endocardial reconstruction of the LV is updated in real time with the acquisition of each new data point and is continuously displayed as unipolar and bipolar voltage potentials on a graded color scale (Figure 6A). The local linear shortening (LLS) function quantifies regional wall motion by obtaining the average change in distance between sample site and adjacent points at end-systole and end-diastole. The mean voltage and LLS values are calculated for each segment and displayed in the polar map. (Figure 6B). The presence of an abnormal or low unipolar potential (&#8804;6 mV) and impaired mechanical activity (LLS &#8804;4%) characterizes infarcted areas22.
<img alt="Figure 1" src="/files/ftp_upload/52450/52450fig1highres.jpg" width="700" /> 
Figure 1:. Rheological assessment of the solutions and gels. (A) Viscosity as a function of shear rate for the solutions at different pH. For the sample at pH 8.5 shear thinning is observed but for the samples at pH 9.0 and 9.5 constant viscosities are obtained, showing the Newtonian behavior of these solutions. (B) Gel curing followed by plotting tan &#948; as a function of time. (C) Frequency sweep for a neutralized sample after 2 hr curing. Error bars show standard deviations of 3 independent measurements, indicating a typical experimental error.
<img alt="Figure 2" src="/files/ftp_upload/52450/52450fig2highres.jpg" width="600" /> 
Figure 2: Setup for degradation and release experiments. (A) Poly(ethylene terephthalate) well insert covered with Parafilm to prevent leakage during preparation. (B) 24-wells plate with inserts, wrapped with Parafilm to prevent evaporation of the solvent.
<img alt="Figure 3" src="/files/ftp_upload/52450/52450fig3highres.jpg" width="700" /> 
Figure 3: Erosion and Release. (A) Erosion of the hydrogel over time. Gradual erosion of the gel for at least 2 weeks is observed. (B) Release of a small molecule drug and a model protein. While the small molecule is released within a day, the model protein is gradually released over a week without a significant burst release. The line shows the fit of the Korsmeyer-Peppas model to the initial stage of the release.
<img alt="Figure 4" src="/files/ftp_upload/52450/52450fig4highres.jpg" width="600" /> 
Figure 4: The catheter navigation system. Communication unit console with NOGA XP Cardiac Navigation System.
<img alt="Figure 5" src="/files/ftp_upload/52450/52450fig5highres.jpg" width="700" /> 
Figure 5: (A) The intramyocardial injection catheter with syringe attached. (B) Detail of injection needle.
<img alt="Figure 6" src="/files/ftp_upload/52450/52450fig6highres.jpg" width="700" /> 
Figure 6: Unipolar voltage and LLS map. (A) Unipolar map, LAO view (top) and bulls eye (below). Red color indicates low unipolar voltage values at myocardial base (normal) with loss of electrical activity posterolateral. Blue indicates normal myocardium, whilst green and yellow colors indicate decreased viability. (B) LLS map, LAO view (top) and bulls eye (below). Red color indicates akinesia in the posterolateral wall, green and yellow indicate decreased wall motion. The mapping points are shown by white dots. The drawn white line shows the area of interest, characterized by decreased unipolar voltages and impaired wall motions. Brown points represent the injection sites.

Watch this Scientific Journal Video about An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart at JoVE.com

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

Supramolecular hydrogelators based on ureido-pyrimidinones allow full control over the macroscopic gel properties and the sol&#8211;gel switching behavior using pH. Here, we present a protocol for formulating and injecting such a supramolecular hydrogelator via a catheter delivery system for local delivery directly in relevant areas in the pig heart.

Regeneration of lost myocardium is an important goal for future therapies because of the increasing occurrence of chronic ischemic heart failure and the ...

an-injectable-drug-loaded-supramolecular-hydrogel-for-local-catheter

Research

JoVE Journal

Bioengineering

17.2K ビュー.  Eindhoven University of Technology. ウレイドピリミジノンに基づく超分子hydrogelatorsは巨視的なゲル特性およびpHを使用したゾル - ゲル切り替え動作を完全に制御することができます。ここでは、ブタの心臓における関連分野での直接局所送達のためのカテーテル送達システムを介して、このような超分子ヒドロゲル化を策定し、及び注入するためのプロトコルを提示します。 

ビデオ: An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

This protocol provides methods for the preparation of an injectable extracellular matrix (ECM) gel for myocardial tissue engineering applications. Briefly, decellularized tissue is lyophilized, milled, enzymatically digested, and then brought to physiological pH. The lyophilization removes all water content from the tissue, resulting in dry ECM that can be ground into a fine powder with a small mill. After milling, the ECM powder is digested with pepsin to form an injectable matrix. After adjustment to pH 7.4, the liquid matrix material can be injected into the myocardium. Results of previous characterization assays have shown that matrix gels produced from decellularized pericardial and myocardial tissue retain native ECM components, including diverse proteins, peptides and glycosaminoglycans. Given the use of this material for tissue engineering, in vivo characterization is especially useful; here, a method for performing an intramural injection into the left ventricular (LV) free wall is presented as a means of analyzing the host response to the matrix gel in a small animal model. Access to the chest cavity is gained through the diaphragm and the injection is made slightly above the apex in the LV free wall. The biologically derived scaffold can be visualized by biotin-labeling before injection and then staining tissue sections with a horse radish peroxidase-conjugated neutravidin and visualizing via diaminobenzidine (DAB) staining. Analysis of the injection region can also be done with histological and immunohistochemical staining. In this way, the previously examined pericardial and myocardial matrix gels were shown to form fibrous, porous networks and promote vessel formation within the injection region.

Methods for preparing an injectable matrix gel from decellularized tissue and injecting it into rat myocardium in vivo are described.

This protocol provides methods for the preparation of an injectable extracellular matrix (ECM) gel for myocardial tissue engineering applications.  ...

Synthesis of an Intein-mediated Artificial Protein Hydrogel

We present the synthesis of a highly stable protein hydrogel mediated by a split-intein-catalyzed protein trans-splicing reaction. The building blocks of this hydrogel are two protein block-copolymers each containing a subunit of a trimeric protein that serves as a crosslinker and one half of a split intein. A highly hydrophilic random coil is inserted into one of the block-copolymers for water retention. Mixing of the two protein block copolymers triggers an intein trans-splicing reaction, yielding a polypeptide unit with crosslinkers at either end that rapidly self-assembles into a hydrogel. This hydrogel is very stable under both acidic and basic conditions, at temperatures up to 50 &#176;C, and in organic solvents. The hydrogel rapidly reforms after shear-induced rupture. Incorporation of a &#34;docking station peptide&#34; into the hydrogel building block enables convenient incorporation of &#34;docking protein&#34;-tagged target proteins. The hydrogel is compatible with tissue culture growth media, supports the diffusion of 20 kDa molecules, and enables the immobilization of bioactive globular proteins. The application of the intein-mediated protein hydrogel as an organic-solvent-compatible biocatalyst was demonstrated by encapsulating the horseradish peroxidase enzyme and corroborating its activity.

We present the synthesis of a split-intein-mediated protein hydrogel. The building blocks of this hydrogel are two protein copolymers each containing a subunit of a trimeric protein that serves as a crosslinker and one half of a split intein. Mixing of the two protein copolymers triggers an intein trans-splicing reaction, yielding a polypeptide unit that self-assembles into a hydrogel. This hydrogel is highly pH- and temperature-stable, compatible with organic solvents, and easily incorporates functional globular proteins.

We present the synthesis of a highly stable protein hydrogel mediated by a split-intein-catalyzed protein trans-splicing reaction. The building blocks of ...

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

To upgrade traditional 2D cell culture to 3D cell culture, we have integrated microfabrication with cryogelation technology to produce macroporous microscale cryogels (microcryogels), which can be loaded with a variety of cell types to form 3D microtissues. Herein, we present the protocol to fabricate versatile 3D microtissues and their applications in regenerative therapy and drug screening. Size and shape-controllable microcryogels can be fabricated on an array chip, which can be harvested off-chip as individual cell-loaded carriers for injectable regenerative therapy or be further assembled on-chip into 3D microtissue arrays for high-throughput drug screening. Due to the high elastic nature of these microscale cryogels, the 3D microtissues exhibit great injectability for minimally invasive cell therapy by protecting cells from mechanical shear force during injection. This ensures enhanced cell survival and therapeutic effect in the mouse limb ischemia model. Meanwhile, assembly of 3D microtissue arrays in a standard 384-multi-well format facilitates the use of common laboratory facilities and equipment, enabling high-throughput drug screening on this versatile 3D cell culture platform.

This protocol describes the fabrication of elastic 3D macroporous microcryogels by integrating microfabrication with cryogelation technology. Upon loading with cells, 3D microtissues are generated, which can be readily injected in vivo to facilitate regenerative therapy or assembled into arrays for in vitro high-throughput drug screening.

To upgrade traditional 2D cell culture to 3D cell culture, we have integrated microfabrication with cryogelation technology to produce macroporous ...

An Additive Manufacturing Technique for the Facile and Rapid Fabrication of Hydrogel-based Micromachines with Magnetically Responsive Components

Polyethylene glycol (PEG)-based hydrogels are biocompatible hydrogels that have been approved for use in humans by the FDA. Typical PEG-based hydrogels have simple monolithic architectures and often function as scaffolding materials for tissue engineering applications. More sophisticated structures typically take a long time to fabricate and do not contain moving components. This protocol describes a photolithography method that allows for facile and rapid microfabrication of PEG structures and devices. This strategy involves an in-house developed fabrication stage that allows for the rapid fabrication of 3D structures by building upwards in a layer-by-layer fashion. Independent moving components can also be aligned and assembled onto support structures to form integrated devices. These independent components are doped with superparamagnetic iron oxide nanoparticles that are sensitive to magnetic actuation. In this manner, the fabricated devices can be actuated using external magnets to yield movement of the components within. Hence, this technique allows for the fabrication of sophisticated MEMS-like devices (micromachines) that are composed entirely out of a biocompatible hydrogel, able to function without an onboard power source, and respond to a contact-less method of actuation. This manuscript describes the fabrication of both the fabrication set-up as well as the step-by-step method for the microfabrication of these hydrogels-based MEMS-like devices.

An additive manufacturing strategy for processing UV-crosslinkable hydrogels has been developed. This strategy allows for the layer-by-layer assembly of microfabricated hydrogel structures as well as the assembly of independent components, yielding integrated devices containing moving components that are responsive to magnetic actuation.

Polyethylene glycol (PEG)-based hydrogels are biocompatible hydrogels that have been approved for use in humans by the FDA. Typical PEG-based hydrogels ...

Syringe-injectable Mesh Electronics for Stable Chronic Rodent Electrophysiology

Implantable brain electrophysiology probes are valuable tools in neuroscience due to their ability to record neural activity with high spatiotemporal resolution from shallow and deep brain regions. Their use has been hindered, however, by mechanical and structural mismatches between the probes and brain tissue that commonly lead to micromotion and gliosis with resulting signal instability in chronic recording experiments. In contrast, following the implantation of ultraflexible mesh electronics via syringe injection, the mesh probes form a seamless, gliosis-free interface with the surrounding brain tissue that enables stable tracking of individual neurons on at least a year timescale. This protocol details the key steps in a typical mouse neural recording experiment using syringe-injectable mesh electronics, including the fabrication of mesh electronics in a standard photolithography-based process possible at many universities, loading mesh electronics into standard capillary needles, stereotaxic injection in vivo, connection of the mesh input/output to standard instrumentation interfaces, restrained or freely moving recording sessions, and histological sectioning of brain tissue containing mesh electronics. Representative neural recordings and histology data are presented. Investigators familiar with this protocol will have the knowledge necessary to incorporate mesh electronics into their own experiments and take advantage of the unique opportunities afforded by long-term stable neural interfacing, such as studies of aging processes, brain development, and the pathogenesis of brain disease.

Mesh electronics probes seamlessly integrate and provide stable, long-term, single-neuron level recording within the brain. This protocol uses mesh electronics for in vivo experiments, involving the fabrication of mesh electronics, loading into needles, stereotaxic injection, input/output interfacing, recording experiments, and histology of tissue containing mesh probes.

Implantable brain electrophysiology probes are valuable tools in neuroscience due to their ability to record neural activity with high spatiotemporal ...

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Absorbance spectroscopy of cardiac muscle provides non-destructive assessment of cytosolic and mitochondrial oxygenation via myoglobin and cytochrome absorbance respectively. In addition, numerous aspects of the mitochondrial metabolic status such as membrane potential and substrate entry can also be estimated. To perform cardiac wall transmission optical spectroscopy, a commercially available side-firing optical fiber catheter is placed in the left ventricle of the isolated perfused heart as a light source. Light passing through the heart wall is collected with an external optical fiber to perform optical spectroscopy of the heart in near real- time. The transmission approach avoids numerous surface scattering interference occurring in widely used reflection approaches. Changes in transmural absorbance spectra were deconvolved using a library of chromophore reference spectra, providing quantitative measures of all the known cardiac chromophores simultaneously. This spectral deconvolution approach eliminated intrinsic errors that may result from using common dual wavelength methods applied to overlapping absorbance spectra, as well as provided a quantitative evaluation of the goodness of fit. A custom program was designed for data acquisition and analysis, which permitted the investigator to monitor the metabolic state of the preparation during the experiment. These relatively simple additions to the standard heart perfusion system provide a unique insight into the metabolic state of the heart wall in addition to conventional measures of contraction, perfusion, and substrate/oxygen extraction.

Here we introduce a method for using an intra-ventricle optical catheter in perfused hearts to perform absorbance spectroscopy across the heart wall. The data obtained provides robust information on tissue oxygen tension as well as substrate utilization and membrane potential simultaneously with cardiac performance measures in this ubiquitous preparation.

Absorbance spectroscopy of cardiac muscle provides non-destructive assessment of cytosolic and mitochondrial oxygenation via myoglobin and cytochrome ...

Biaxial Mechanical Characterizations of Atrioventricular Heart Valves

Extensive biaxial mechanical testing of the atrioventricular heart valve leaflets can be utilized to derive&#160;optimal parameters used in constitutive models, which provide a mathematical representation of the mechanical function of those structures. This presented biaxial mechanical testing protocol involves (i) tissue acquisition, (ii) the preparation of tissue specimens, (iii) biaxial mechanical testing, and (iv) postprocessing of the acquired data. First, tissue acquisition requires obtaining porcine or ovine hearts from a local Food and Drug Administration-approved abattoir for later dissection to retrieve the valve leaflets. Second, tissue preparation requires using tissue specimen cutters on the leaflet tissue to extract a clear zone for testing. Third, biaxial mechanical testing of the leaflet specimen requires the use of a commercial biaxial mechanical tester, which consists of force-controlled, displacement-controlled, and stress-relaxation testing protocols to characterize the leaflet tissue&#39;s mechanical properties. Finally, post-processing requires the use of data image correlation techniques and force and displacement readings to summarize the tissue&#39;s mechanical behaviors in response to external loading. In general, results from biaxial testing demonstrate that the leaflet tissues yield a nonlinear, anisotropic mechanical response. The presented biaxial testing procedure is advantageous to other methods since the method presented here allows for a more comprehensive characterization of the valve leaflet tissue under one unified testing scheme, as opposed to separate testing protocols on different tissue specimens. The proposed testing method has its limitations in that shear stress is potentially present in the tissue sample. However, any potential shear is presumed negligible.

This protocol involves characterizations of atrioventricular valve leaflets with force-controlled, displacement-controlled, and stress-relaxation biaxial mechanical testing procedures. Results acquired with this protocol can be used for constitutive model development to simulate the mechanical behavior of functioning valves under a finite element simulation framework.

Extensive biaxial mechanical testing of the atrioventricular heart valve leaflets can be utilized to derive&#160;optimal parameters used in constitutive ...

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

These methods describe how to formulate injectable, supramolecular polymer-nanoparticle (PNP) hydrogels for&#160;use as biomaterials. PNP hydrogels are composed of two components: hydrophobically modified cellulose as the network polymer and self-assembled core-shell nanoparticles that act as non-covalent cross linkers through dynamic, multivalent interactions. These methods describe both the formation of these self-assembled nanoparticles through nanoprecipitation as well as the formulation and mixing of the two components to form hydrogels with tunable mechanical properties. The use of dynamic light scattering (DLS) and rheology to characterize the quality of the synthesized materials is also detailed. Finally, the utility of these hydrogels for drug delivery, biopharmaceutical stabilization, and cell encapsulation and delivery is demonstrated through in vitro experiments to characterize&#160;drug release, thermal stability, and cell settling and viability. Due to its biocompatibility, injectability, and mild gel formation conditions, this hydrogel system is a readily tunable platform suitable for a range of biomedical applications.

This protocol describes the synthesis and formulation of injectable, supramolecular polymer-nanoparticle (PNP) hydrogel biomaterials. Applications of these materials for drug delivery, biopharmaceutical stabilization, and cell encapsulation and delivery are demonstrated.

These methods describe how to formulate injectable, supramolecular polymer-nanoparticle (PNP) hydrogels for&#160;use as biomaterials. PNP hydrogels are ...

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation

Biologists have long attempted to understand the relationship between phenotype and genotype. To better understand this connection, it is crucial to develop practical technologies that couple microscopic cell screening with cell isolation at high purity for downstream genetic analysis. Here, the use of photodegradable poly(ethylene glycol) hydrogels for screening and isolation of bacteria with unique growth phenotypes from heterogeneous cell populations is described. The method relies on encapsulating or entrapping cells with the hydrogel, followed by culture, microscopic screening, then use of a high-resolution light patterning tool for spatiotemporal control of hydrogel degradation and release of selected cells into a solution for retrieval. Applying different light patterns allows for control over the morphology of the extracted cell, and patterns such as rings or crosses can be used to retrieve cells with minimal direct UV light exposure to mitigate DNA damage to the isolates. Moreover, the light patterning tool delivers an adjustable light dose to achieve various degradation and cell release rates. It allows for degradation at high resolution, enabling cell retrieval with micron-scale spatial precision. Here, the use of this material to screen and retrieve bacteria from both bulk hydrogels and microfabricated lab-on-a-chip devices is demonstrated. The method is inexpensive, simple, and can be used for common and emerging applications in microbiology, including isolation of bacterial strains with rare growth profiles from mutant libraries and isolation of bacterial consortia with emergent phenotypes for genomic characterizations.

The use of photodegradable hydrogels to isolate bacterial cells by utilizing a high-resolution light pattering tool is reported. Essential experimental procedures, results, and advantages of the process are reviewed. The method enables rapid and inexpensive isolation of targeted bacteria showing rare or unique functions from heterogeneous communities or populations.

Biologists have long attempted to understand the relationship between phenotype and genotype. To better understand this connection, it is crucial to ...

Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart

The ability to measure biomarkers in vivo relevant to the assessment of disease progression is of great interest to the scientific and medical communities. The resolution of results obtained from current methods of measuring certain biomarkers can take several days or weeks to obtain, as they can be limited in resolution both spatially and temporally (e.g., fluid compartment microdialysis of interstitial fluid analyzed by enzyme-linked immunosorbent assay [ELISA], high-performance liquid chromatography [HPLC], or mass spectrometry); thus, their guidance of timely diagnosis and treatment is disrupted. In the present study, a unique technique for detecting and measuring peptide transmitters in vivo through the use of a capacitive immunoprobe biosensor (CI probe) is reported. The fabrication protocol and in vitro characterization of these probes are described. Measurements of sympathetic stimulation-evoked neuropeptide Y (NPY) release in vivo are provided. NPY release is correlated to the sympathetic release of norepinephrine for reference. The data demonstrate an approach for the fast and localized measurement of neuropeptides in vivo. Future applications include intraoperative real-time assessment of disease progression and minimally invasive catheter-based deployment of these probes.

Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart

Established immunochemical methods to measure peptide transmitters in vivo rely on microdialysis or bulk fluid draw to obtain the sample for offline analysis. However, these suffer from spatiotemporal limitations. The present protocol describes the fabrication and application of a capacitive immunoprobe biosensor that overcomes the limitations of the existing techniques.